10A N.C. Admin. Code 26F.0105

Current through Register Vol. 39, No. 9, November 1, 2024

Section 26F .0105 - SCHEDULE IV

(a) Schedule IV shall consist of the drugs and other substances by whatever official name, common or usual name, chemical name, or brand name designated and listed in either G.S. 90-92 or this Rule. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) controlled substances code number set forth in the Code of Federal Regulations, Title 21, Section 1308.l4.

(b) As specified in G.S. 90-88, the Commission for MH/DD/SAS adds the following substances within Schedule IV for Depressants:

(1) Dichloralphenazone - DEA controlled substances code number 2467;

(2) Zopiclone - DEA controlled substances code number 2784;

(3) Fosporopol - DEA controlled substances code number 2138;

(4) Carisoprodol - DEA controlled substances code number 8192;

(5) Lemborexant - DEA controlled substances code number 2245; and

(6) Remimazolam - DEA controlled substances code number 2846.

(c) As specified in G.S. 90-88, the Commission for MH/DD/SAS adds the following substances within Schedule IV for Stimulants: Serdexmethylphenidate - DEA controlled substances code number 1729.

10A N.C. Admin. Code 26F .0105

Authority G.S. 90-88; 90-92; 143B-147;
Eff. June 30, 1978;
Amended Eff. July 1, 1993; January 1, 1989; December 1, 1987; August 1, 1987;
Temporary Amendment Eff. May 28, 1998;
Temporary Amendment Expired March 12, 1999;
Amended Eff. August 1, 2000;
Temporary Amendment Eff. January 1, 2002; February 15, 2001;
Amended Eff. July 1, 2012; July 1, 2011; November 1, 2005; April 1, 2003; August 1, 2002;
Pursuant to G.S. 150B-21.3A, rule is necessary without substantive public interest Eff. February 2, 2016;
Amended Eff. December 1, 2021.

Amended by North Carolina Register Volume 36, Issue 13, January 3, 2022 effective 12/1/2021.